Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatitis B reactivation related to everolimus.
Sezgin Göksu S, Bilal S, Coşkun HŞ. Sezgin Göksu S, et al. World J Hepatol. 2013 Jan 27;5(1):43-5. doi: 10.4254/wjh.v5.i1.43. World J Hepatol. 2013. PMID: 23383366 Free PMC article.
Use of chemotherapy at the end of life in Turkey.
Sezgin Goksu S, Gunduz S, Unal D, Uysal M, Arslan D, Tatlı AM, Bozcuk H, Ozdogan M, Coskun HS. Sezgin Goksu S, et al. BMC Palliat Care. 2014 Nov 19;13(1):51. doi: 10.1186/1472-684X-13-51. eCollection 2014. BMC Palliat Care. 2014. PMID: 25435808 Free PMC article.
Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer.
Arslan D, Tural D, Koca T, Tastekin D, Kaymak Cerkesli A, Basaran H, Gunduz S, Murat Tatli A, Sezgin Goksu S, Uysal M, Kargi A, Kargi B, Koral L, Ibrahim Bassorgun C, Unal D, Mutlu H, Senol Coskun H, Ozdogan M, Bozcuk H. Arslan D, et al. Among authors: sezgin goksu s. J BUON. 2015 Mar-Apr;20(2):573-9. J BUON. 2015. PMID: 26011352 Free article.
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
Alkan A, Yaşar A, Güç ZG, Gürbüz M, Başoğlu T, Sezgin Göksu S, Buğdaycı Başal F, Türk HM, Özdemir Ö, Yeşil Çınkır H, Güven DC, Kuş T, Türker S, Koral L, Karakaş Y, Ak N, Paydaş S, Karcı E, Demiray AG, Demir A, Alan Ö, Keskin Ö, Nayır E, Tanrıverdi Ö, Yavuzşen T, Yumuk PF, Ateş Ö, Coşkun HŞ, Turhal S, Çay Şenler F. Alkan A, et al. Among authors: sezgin goksu s. Eur J Cancer Care (Engl). 2020 Nov;29(6):e13296. doi: 10.1111/ecc.13296. Epub 2020 Aug 30. Eur J Cancer Care (Engl). 2020. PMID: 32864838
MicroRNAs as biomarkers for breast cancer.
Canatan D, Sönmez Y, Yılmaz Ö, Çim A, Coşkun HŞ, Sezgin Göksu S, Ucar S, Aktekin MR. Canatan D, et al. Among authors: sezgin goksu s. Acta Biomed. 2021 May 12;92(2):e2021028. doi: 10.23750/abm.v92i2.9678. Acta Biomed. 2021. PMID: 33988168 Free PMC article.
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study.
Bilici A, Uysal M, Menekse S, Akin S, Yildiz F, Turan M, Sezgin Goksu S, Beypinar I, Sakalar T, Değirmenci M, Erdem D, Basaran G, Olmez OF, Avci N, Tural D, Sakin A, Turker S, Demir A, Temiz S, Kaplan MA, Dogan M, Tanriverdi O, Bilgetekin I, Cinkir HY, Acikgoz O, Paydas S, Uslu R, Turhal S. Bilici A, et al. Among authors: sezgin goksu s. Cancer Invest. 2022 Feb;40(2):199-209. doi: 10.1080/07357907.2021.2017952. Epub 2021 Dec 22. Cancer Invest. 2022. PMID: 34894960
20 results